Rapport Pharma - Prakiraan wutah bathi resik saben saham kanggo taun ngarep RAPP

Logo korporat perusahaan Rapport Therapeutics, Inc. (RAPP)

Risks for Rapport Therapeutics, Inc. (RAPP) are linked to massive expenditures and the uncertainty of CNS research outcomes. The projected change in earnings per share for the coming year demonstrates a support level, where -28.30 determines this parameter level. Stability is provided by a team of top biologists with a powerful scientific foundation, while the future scale of the business relies on patents and low drug production costs.

Rapport Pharma (RAPP): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 08.06.2024 nganti 16.11.2026

Ringkesan rincian data analitis Rapport Pharma (RAPP)

Analisis fundamental perusahaan:RAPP, Rapport Therapeutics, Inc.
Produk dadi Rapport Therapeutics Inc

The sensitivity of this metric to operational efficiency determines its ability to measure the consensus growth forecast for net income, which is critical for assessing whether the asset is overvalued relative to its fundamental potential. The current value of -28.30 reflects market expectations for the monetization of innovations in targeted brain receptor neurotherapy for Rapport Therapeutics, Inc. (RAPP), meaning that analyzing the projected trend of net profit allows for the timely detection of a gap between the price and the actual pace of business expansion.

Analisis pesaing Rapport Therapeutics, Inc.

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jazz Pharmaceuticals|CYTK: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PTC Bio (PTCT)|SRRK - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Centessa Pharmaceuticals PLC CNTA|Dyne Pharma (DYN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|EWTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Alumis Inc.|ZVRA: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Contineum Pharma CTNM|Prakiraan wutah bathi saben saham kanggo taun ngarep LRMR|Prakiraan wutah bathi resik saben saham ing taun ngarep Capricor Therapeutics CAPR|Prakiraan wutah bathi kanggo taun ngarep TRDA|Prakiraan wutah bathi saben saham kanggo taun ngarep Channel Therapeutics PTHS|Prakiraan wutah bathi kanggo taun ngarep MNOV (MediciNova)|Dinamika bathi saben saham sing diarepake ing taun ngarep SER|BTAI - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|promisneurosciences.com (PMN) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Apimeds (APUS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AEON|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NLS Pharma|Prakiraan wutah bathi resik saben saham ing taun ngarep bionomics.com.au BNOX|Prakiraan wutah bathi kanggo taun ngarep HUGE|RETA (Reata Pharma) - Dinamika bathi saben saham sing diarepake ing taun ngarep